{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Pliant Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"PLRX"},"Address":{"label":"Address","value":"260 LITTLEFIELD AVENUE, SOUTH SAN FRANCISCO, California, 94080, United States"},"Phone":{"label":"Phone","value":"+1 650 481-6770"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis."},"CompanyUrl":{"label":"Company Url","value":"https://www.pliantrx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Bernard Coulie","title":"President, Chief Executive Officer & Director"},{"name":"Eric Lefebvre","title":"Chief Medical Officer"},{"name":"Gary Palmer","title":"Senior Vice President-Medical Affairs"},{"name":"Gregory P. Cosgrove","title":"Vice President-Clinical Development"},{"name":"Scott Turner","title":"Senior Vice President-Research"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}